Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exparel and Education to Avoid Opioids After Carpal Tunnel Release
NCT03867539Phase 4Recruiting
- Sponsor
- Kettering Health
- Start
- Feb 2019
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of liposomal bupivacaine in carpal tunnel syndrome (CTS) (2 arms), sponsored by Kettering Health. Primary endpoint: Visual Analog Scale for Pain at 72 hours. Started Feb 2019; status: recruiting.
02
Drugs
liposomal bupivacaine
03
Conditions
carpal tunnel syndrome (CTS)
Beyond the preview
Go deeper on NCT03867539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03867539.